Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C35H48Cl5NO4 |
| Molecular Weight | 724.025 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)OC5=C(Cl)C(OC)=NC(=C5Cl)C(Cl)(Cl)Cl)[C@H](C)CCCC(C)C
InChI
InChIKey=ZJUUIXYKTPSIOH-LEZJFEBPSA-N
InChI=1S/C35H48Cl5NO4/c1-19(2)8-7-9-20(3)24-12-13-25-23-11-10-21-18-22(14-16-33(21,4)26(23)15-17-34(24,25)5)44-32(42)45-29-27(36)30(35(38,39)40)41-31(43-6)28(29)37/h10,19-20,22-26H,7-9,11-18H2,1-6H3/t20-,22+,23+,24-,25+,26+,33+,34-/m1/s1
| Molecular Formula | C35H48Cl5NO4 |
| Molecular Weight | 724.025 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:48:46 UTC 2023
by
admin
on
Fri Dec 15 15:48:46 UTC 2023
|
| Record UNII |
1S83F4T2WE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1590
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
||
|
FDA ORPHAN DRUG |
604017
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C90539
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | NCIT | ||
|
300000032237
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | |||
|
16126905
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | |||
|
11547
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | INN | ||
|
1S83F4T2WE
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | |||
|
942149-56-6
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY | |||
|
DB15075
Created by
admin on Fri Dec 15 15:48:46 UTC 2023 , Edited by admin on Fri Dec 15 15:48:46 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Originator: Dekk-Tec; Class: Antineoplastic, Carbonate, Picoline; Mechanism of Action: Alkylating agent, Cell cycle modulator, Cell death stimulant; Highest Development Phases: Phase II for Brain cancer, Brain metastase, Phase I for Solid tumours; Most Recent Events: 09 Feb 2016 DM-CHOC-PEN is still in phase II trials for Brain cancer and Brain metastases in USA (IV), 01 Oct 2013 Dekk Tec completes a phase I trial in Solid tumours (second-line therapy or greater late stage disease) in USA (NCT01048008, NCT01976910), 30 Sep 2013 Phase-II clinical trials in Brain metastases in USA (IV)
|
